Trials / Unknown
UnknownNCT05514041
A Randomized, Controlled, Double-masked, Investigator-initiated Trial to Evaluate Tear Film Quality and Stability in Subjects With Dry Eye Disease Using OC-01 (Varenicline Solution) Nasal Spray 0.03 mg as Compared to Vehicle Control Nasal Spray
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Stephenson Eye Associates · Academic / Other
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
A randomized, controlled, double-masked, investigator-initiated trial to evaluate tear film quality and stability in subjects with dry eye disease using OC-01 (varenicline solution) nasal spray 0.03 mg as compared to vehicle control nasal spray.
Detailed description
A randomized, controlled, double-masked, investigator-initiated trial to evaluate tear film quality and stability in subjects with dry eye disease using OC-01 (varenicline solution) nasal spray 0.03 mg as compared to vehicle control nasal spray.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Varenicline solution | OC-01 nasal spray 0.03 mg |
| DRUG | Placebo nasal spray (OC-01 Vehicle Nasal Spray) | Placebo nasal spray (OC-01 Vehicle Nasal Spray) |
Timeline
- Start date
- 2022-08-29
- Primary completion
- 2023-09-01
- Completion
- 2023-09-01
- First posted
- 2022-08-24
- Last updated
- 2022-08-24
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05514041. Inclusion in this directory is not an endorsement.